Title for MeetingAbstracts
Alphabetical listing of titles
Crystal Structure of HIV-1 RT with Template-Primer Terminated with the Acyclic Nucleotide RT Inhibitor Tenofovir Suggests Mechanisms of Evading Resistance.
CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE.
Crystal Structure of Penicillin Binding Protein PBP2xR from Clinically Resistant Strain (CS109) of Streptococcus pneumoniae.
Crystal Structure of Penicillin-Binding Protein 5' from Escherichia coli at 2.3 A Resolution.
Crystal Structure of Staphylococcus aureus Dehydroquinate Synthase, a Potential Target for Antibacterial Drugs.
Crystal Structure of the Pseudomonas aeruginosa SPM-1 Metallo-b -Lactamase.
Crystal Structures of DNA Ligase from Pathogenic Bacteria Reveal Extensive Structural Conservation and Provide Critical Insight into Protein-Ligand Interaction.
Crystal Structures of HIV-1 Reverse Transcriptase with 4'-ethynyl-2'-deoxyfuranosyl-2,6-diaminopurine Incorporated into the Template-primer.
CRYSTAL STRUCTURES OF HIV-1 RT-DNA COMPLEXES BEFORE AND AFTER INCORPORATION OF TENOFOVIR PROVIDE INSIGHT INTO ITS EFFECTIVENESS AGAINST NRTI-RESISTANCE.
Crystal Structures of the Class D Beta-Lactamase OXA-13 in the Native Form and in Complex with Meropenem.
Crystal structures of the HIV-1 matrix protein (p17).
Crystal structures of the PETT compounds MSC-204 and MSH-372 in complex with human immunodeficiency virus reverse transcriptase. Eleventh International Conference on Antiviral Research.
Crystalline pneumonia in murine infection with Cryptococcus neoformans.
Crystallographic analyses of integrase core domain metal complexes.
Crystallographic Comparison of Cephalosporinases with Different Spectrums of Activity.
Crystallographic structure of HIV reverse transcriptase complexed with an RNA pseudoknot inhibitor.
Crystallographic studies of FIV and EIAV proteases.
Crystallographic Studies on Mycobacterium tuberculosis Dihydropteroate Synthase.
Crytococcal infection in HIV patientes A report of 55 cases.
CS-023 (R-115685), a Novel Parenteral Carbapenem: I. In Vitro and In Vivo Pharmacodynamic (PD) Evaluations against Pseudomonas aeruginosa.
CS-023 (R-115685), a Novel Parenteral Carbapenem: II. In Vitro and In Vivo Activities against Methicillin-Resistant Staphylococcus aureus.
CS-023: An Investigational Carbapenem with Enhanced Activity against Resistant Pathogens.
CS-758 (R-120758), a Novel Triazole Antifungal Agent: Pharmacokinetics and Metabolism after Intravenous Administration of a Solution in Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) to Laboratory Animals.
CS-758 (R-120758), a Novel Triazole Antifungal Agent: Pharmacokinetics and Metabolism in Monkeys.
CSF abnormalities in HIV infected patients and diagnostic difficulties-analyses of 132 cases.
CSF abnormalities in HIV-seropositive patients with latent syphilis.
CSF and plasma viral load and AIDS dementia: a preliminary study.
CSF and serum antigens in AIDS patients with cryptococcal meningitis.
CSF and serum HIV-RNA levels during AZT/3TC and d4T/3TC treatment.
CSF Bactericidal Activity against Cephalosporin-Susceptible, -Intermediate and -Resistant Streptococcus pneumoniae in Patients Receiving Cefotaxime, Cefepime, or a Combination of One of Them with Vancomycin or Rifampin.